TABLE OF CONTENTS
Volume 5, Issue 3 (2005)
In This Issue
Top of pageMeeting Reports
The second annual meeting of the International Society of Pharmacogenomics (ISP)—a joint meeting with the Pacific Rim association for Clinical Pharmacogenetics (PRACPG)
L J Sheffield
Pharmacogenomics J 5: 144-145; advance online publication, April 26, 2005; doi:10.1038/sj.tpj.6500310
The third annual meeting of the International Society of Pharmacogenomics (ISP): a joint meeting with the International Union of Nutritional Sciences (IUNS) task force on genetics and nutrition
L J Sheffield
Pharmacogenomics J 5: 146-148; advance online publication, April 26, 2005; doi:10.1038/sj.tpj.6500311
Original Articles
Sequencing drug response with HapMap
M Lin, C Aquilante, J A Johnson and R Wu
Pharmacogenomics J 5: 149-156; advance online publication, March 22, 2005; doi:10.1038/sj.tpj.6500302
Functional analysis of genetic variants in the human concentrative nucleoside transporter 3 (CNT3; SLC28A3)
I Badagnani, W Chan, R A Castro, C M Brett, C C Huang, D Stryke, M Kawamoto, S J Johns, T E Ferrin, E J Carlson, E G Burchard and K M Giacomini
Pharmacogenomics J 5: 157-165; advance online publication, March 1, 2005; doi:10.1038/sj.tpj.6500303
Mapping and verification of susceptibility loci for smoking quantity using permutation linkage analysis
D Wang, J Z Ma and M D Li
Pharmacogenomics J 5: 166-172; advance online publication, February 22, 2005; doi:10.1038/sj.tpj.6500304
Identification and characterization of novel sequence variations in the cytochrome P4502D6 (CYP2D6) gene in African Americans
A Gaedigk, A Bhathena, L Ndjountché, R E Pearce, S M Abdel-Rahman, S W Alander, L DiAnne Bradford and J Steven Leeder
Pharmacogenomics J 5: 173-182; advance online publication, March 15, 2005; doi:10.1038/sj.tpj.6500305
Systematic investigation of genetic variability in 111 human genes—implications for studying variable drug response
Y Freudenberg-Hua, J Freudenberg, J Winantea, N Kluck, S Cichon, M Brüss, P Propping and M M Nöthen
Pharmacogenomics J 5: 183-192; advance online publication, April 5, 2005; doi:10.1038/sj.tpj.6500306
Influence of CYP2C9 polymorphisms, demographic factors and concomitant drug therapy on warfarin metabolism and maintenance dose
D Herman, I Locatelli, I Grabnar, P Peternel, M Stegnar, A Mrhar, K Breskvar and V Dolzan
Pharmacogenomics J 5: 193-202; advance online publication, April 12, 2005; doi:10.1038/sj.tpj.6500308
Distinct proteomic profiles of amphetamine self-administration transitional states
W M Freeman, K Brebner, S G Amara, M S Reed, J Pohl and A G Phillips
Pharmacogenomics J 5: 203-214; advance online publication, April 26, 2005; doi:10.1038/sj.tpj.6500309
